ARYLACYLSULFONAMIDE ALS BLT1-ANTAGONISTEN

Patent europeic · EP3383389 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3383389
Numer da la dumonda
EP16871302
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
28-11-2016
Publitgà
10-10-2018
Concedì
28-04-2021
Stritgà
30-06-2022
Motiv
Taxa annuala betg pajada
Classas IPC
C07D 417/14 (2006.01)
A61K 31/44 (2006.01)
A61P 3/10 (2006.01)
Prioritad
US 201562260937 P 30.11.2015
Dumonda PCT
PCT/US2016/063807 28.11.2016
Publicaziun PCT
WO2017/095723 08.06.2017
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 30-06-2022

    Stritgà, taxa betg pajada

    Published in Swissreg on 30.06.2022

  2. 09-03-2022

    Midada

    Published in Swissreg on 09.03.2022

  3. 28-04-2021

    Concedì

    Published in Swissreg on 28.04.2021

Partidas

Possessur

Merck Sharp & Dohme Corp.

126 East Lincoln Avenue, Rahway, NJ 07065-0907, US

Inventur

HAN, Yongxin

Boston Massachusetts 02115-5727, US

SPENCER, Kerrie

Boston Massachusetts 02115-5727, US

SILIPHAIVANH, Phieng

Boston Massachusetts 02115-5727, US

TUMMANAPALLI, Satyanarayana

Albany New York 12203, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.